D E Bergsagel

1.6k total citations
17 papers, 832 citations indexed

About

D E Bergsagel is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, D E Bergsagel has authored 17 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in D E Bergsagel's work include Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (3 papers). D E Bergsagel is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (3 papers). D E Bergsagel collaborates with scholars based in Canada, New Zealand and United States. D E Bergsagel's co-authors include Margaret A. Knowling, Andrew R. Harwood, Kenneth M. Griffith, Christopher P. Austin, T. Chua, Simon Sutcliffe, Héctor Martínez-Valdez, MD Minden, HA Messner and R. S. Bush and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

D E Bergsagel

17 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D E Bergsagel Canada 11 487 299 285 258 150 17 832
Jens Ersbøll Denmark 15 371 0.8× 381 1.3× 276 1.0× 449 1.7× 282 1.9× 29 1.1k
Burton J. Lee United States 15 220 0.5× 436 1.5× 166 0.6× 568 2.2× 191 1.3× 19 952
SN Wolff United States 10 421 0.9× 397 1.3× 133 0.5× 277 1.1× 229 1.5× 13 822
Christos Kiamouris Greece 12 439 0.9× 329 1.1× 278 1.0× 213 0.8× 284 1.9× 19 852
J. L. Harousseau France 14 436 0.9× 293 1.0× 199 0.7× 187 0.7× 163 1.1× 35 812
Jorge A. Spinolo United States 11 379 0.8× 436 1.5× 150 0.5× 109 0.4× 90 0.6× 18 794
G. Ucci Italy 19 463 1.0× 355 1.2× 357 1.3× 92 0.4× 200 1.3× 61 931
Alain Sadoun France 12 432 0.9× 249 0.8× 131 0.5× 158 0.6× 209 1.4× 28 820
Paolo Gavarotti Italy 17 251 0.5× 315 1.1× 126 0.4× 501 1.9× 130 0.9× 36 829
M. L. Vegna Italy 14 765 1.6× 296 1.0× 517 1.8× 186 0.7× 218 1.5× 20 1.2k

Countries citing papers authored by D E Bergsagel

Since Specialization
Citations

This map shows the geographic impact of D E Bergsagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Bergsagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Bergsagel more than expected).

Fields of papers citing papers by D E Bergsagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D E Bergsagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Bergsagel. The network helps show where D E Bergsagel may publish in the future.

Co-authorship network of co-authors of D E Bergsagel

This figure shows the co-authorship network connecting the top 25 collaborators of D E Bergsagel. A scholar is included among the top collaborators of D E Bergsagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D E Bergsagel. D E Bergsagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bergsagel, D E, Otto Wong, P. Leif Bergsagel, et al.. (1999). Benzene and multiple myeloma: appraisal of the scientific evidence.. PubMed. 94(4). 1174–82. 39 indexed citations
2.
Gospodarowicz, Mary, Simon Sutcliffe, Roy M. Clark, et al.. (1992). Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. International Journal of Radiation Oncology*Biology*Physics. 22(5). 859–865. 55 indexed citations
3.
Gospodarowicz, Mary, Simon Sutcliffe, D E Bergsagel, & T. Chua. (1992). Radiation therapy in clinical stage I and II Hodgkin's disease. European Journal of Cancer. 28(11). 1841–1846. 32 indexed citations
4.
Bergsagel, D E. (1992). Myeloma, melphalan, and meta-analysis.. Journal of Clinical Oncology. 10(2). 178–179. 4 indexed citations
5.
Yelle, Louise, D E Bergsagel, V. Basco, et al.. (1991). Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.. Journal of Clinical Oncology. 9(11). 1983–1993. 28 indexed citations
6.
7.
8.
Wilson, Kenneth S., W Shelley, Andrew R. Belch, et al.. (1987). Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.. PubMed. 71(10). 981–2. 8 indexed citations
9.
Sutcliffe, Simon, M. Gospodarowicz, D E Bergsagel, et al.. (1985). Prognostic groups for management of localized Hodgkin's disease.. Journal of Clinical Oncology. 3(3). 393–401. 78 indexed citations
10.
Takahashi, Tohru, Bing Lim, N Jamal, et al.. (1985). Colony growth and self renewal of plasma cell precursors in multiple myeloma.. Journal of Clinical Oncology. 3(12). 1613–1623. 29 indexed citations
11.
Knowling, Margaret A., Andrew R. Harwood, & D E Bergsagel. (1983). Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone.. Journal of Clinical Oncology. 1(4). 255–262. 294 indexed citations
12.
Ogawa, Makio, et al.. (1972). Differential effects of chemotherapeutic agents on mouse myeloma and hemopoietic stem cells. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 934. 1 indexed citations
13.
Bergsagel, D E. (1971). Total body irradiation for myelomatosis.. BMJ. 2(5757). 325.2–325. 35 indexed citations
14.
Bergsagel, D E, et al.. (1962). Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).. PubMed. 21. 101–6. 4 indexed citations
15.
Arrighi, F, et al.. (1962). Chromosome damage in murine and human cells following cytoxan therapy.. The Mouseion at the JAXlibrary (Jackson Laboratory). 545. 36 indexed citations
16.
Bergsagel, D E, et al.. (1962). Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).. PubMed. 21. 87–99. 97 indexed citations
17.
Bergsagel, D E, Robert E. Beamish, & J. C. Wilt. (1952). BRUCELLA ARTHRITIS OF THE HIP JOINT: A REVIEW OF THE LITERATURE AND REPORT OF A CASE TREATED WITH TERRAMYCIN. Annals of Internal Medicine. 37(4). 767–776. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Ersbøll Breakdown of academic impact, for papers by Burton J. Lee Breakdown of academic impact, for papers by SN Wolff Breakdown of academic impact, for papers by Christos Kiamouris Breakdown of academic impact, for papers by J. L. Harousseau Breakdown of academic impact, for papers by Jorge A. Spinolo Breakdown of academic impact, for papers by G. Ucci Breakdown of academic impact, for papers by Alain Sadoun Breakdown of academic impact, for papers by Paolo Gavarotti Breakdown of academic impact, for papers by M. L. Vegna
Rankless by CCL
2026